Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion‐dependent thalassemia patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2018-10, Vol.93 (10), p.E338-E340
Hauptverfasser:	Pinto, Valeria Maria, Balocco, Manuela, Quintino, Sabrina, Bacigalupo, Lorenzo, Gianesin, Barbara, Rizzi, Monica, Malagò, Roberto, De Franceschi, Lucia, Forni, Gian Luca
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Blood Transfusion Chelation Therapy - methods Deferasirox - administration & dosage Deferasirox - therapeutic use Deferiprone - administration & dosage Deferiprone - therapeutic use Drug Administration Schedule Drug Synergism Female Follow-Up Studies Hematology Humans Iron - metabolism Iron Chelating Agents - administration & dosage Iron Chelating Agents - therapeutic use Iron Overload - drug therapy Iron Overload - etiology Iron Overload - prevention & control Male Thalassemia Thalassemia - complications Thalassemia - therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!